Medical Health & Life Science Research News

New study: Middle East & Africa's preventive vaccine market forecasts 2016–2021

Medical Market Research

Middle-East & Africa Preventive Vaccine market by Vaccine Type (Live, Attenuated vaccines, Inactivated vaccines, Toxoid vaccines, Subunit vaccines, Conjugate vaccines, DNA vaccines and Recombinant vector vaccines), by End User (Paediatric and Adult Vaccines) and by Region

The Middle-East & Africa Preventive Vaccine market is valued at $2.42 Billion in 2015 and is predicted to reach $ 4.28 billion by 2020 at an annual growth rate of 12.07 %. Recently there has been a substantial growth in the vaccine market with the rising incidences of cancer & HIV cases.

World Health Organization growth estimations indicate the market may increase in value to almost 54.5 billion 2020, with the arrival of new therapeutic preventive, and adult vaccines.

View Full Report @…ccine-market-145/ Make an Inquiry about this news

The vaccine Market is different from other product markets.

Although it is relatively small compared to the pharmaceutical market, it has a tremendous growing opportunities and is growing at a faster rate. Major players of the market have already been investing heavily in the vaccine market and as many as 120 new vaccines are in the pipeline of these companies.

Request Sample @…45/request-sample Make an Inquiry about this news

The higher growth rate of the market is attributed to the drivers like, increase funding from the government for vaccine development, huge investments by the multinational companies in the R&D department of the preventive vaccines, technological advancements making it easier for new innovations, initiatives by NGO’s. However, there are few restrains that the market has to overcome like high capital expenditures, stringent policies by the government, high cost of treatment.

Inquire Report @…arket-145/inquire Make an Inquiry about this news

Market Segmentation                                              

          By Vaccine Type                       

  • Live, Attenuated Vaccines
  • Inactivted Vaccines             
  • Toxoid Vaccines    
  • Subunit vaccines  
  • Conjugate vaccines             
  • DNA vaccines         
  • Recombinant vector vaccines          

         By End User               

  • Paediatric Vaccine
  • Pneumococcal
  • MMR
  • Varicella
  • Hepatitis
  • Poliovirus
  • HIB
  • Others

            Adult Vaccines      

  • Influenza
  • Cervical Cancer
  • Hepatitis
  • Zoster
  • Others

Historically many of the multinational vaccine companies have been investing huge sums in research and development resulting in new innovations in the market. The major players in the preventive vaccine market are GlaxoSmithKline, plc, Merck and Company, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Novartis AG, Johnson and Johnson, MedImmune, LLC, Pfizer, Inc., and Sanofi Pasteur.

Enquire Now @…ccine-market-145/ Make an Inquiry about this news

News From

Market Data Forecast - market research, business intelligence and consultingMarket Data Forecast
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
This email address is being protected from spambots. You need JavaScript enabled to view it.

For more information:

Make an Inquiry about this report HERE!